CO6990739A2 - Administración eficiente de lípidos a la película lagrimal humana mediante el uso de un sistema de emulsión sensible a la sal - Google Patents

Administración eficiente de lípidos a la película lagrimal humana mediante el uso de un sistema de emulsión sensible a la sal

Info

Publication number
CO6990739A2
CO6990739A2 CO14138315A CO14138315A CO6990739A2 CO 6990739 A2 CO6990739 A2 CO 6990739A2 CO 14138315 A CO14138315 A CO 14138315A CO 14138315 A CO14138315 A CO 14138315A CO 6990739 A2 CO6990739 A2 CO 6990739A2
Authority
CO
Colombia
Prior art keywords
lipids
salt
tear film
sensitive emulsion
emulsion system
Prior art date
Application number
CO14138315A
Other languages
English (en)
Inventor
Joseph G Vehige
Peter A Simmons
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47459152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6990739(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of CO6990739A2 publication Critical patent/CO6990739A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/717Celluloses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CO14138315A 2011-12-07 2014-06-26 Administración eficiente de lípidos a la película lagrimal humana mediante el uso de un sistema de emulsión sensible a la sal CO6990739A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161568089P 2011-12-07 2011-12-07
US201261625401P 2012-04-17 2012-04-17

Publications (1)

Publication Number Publication Date
CO6990739A2 true CO6990739A2 (es) 2014-07-10

Family

ID=47459152

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14138315A CO6990739A2 (es) 2011-12-07 2014-06-26 Administración eficiente de lípidos a la película lagrimal humana mediante el uso de un sistema de emulsión sensible a la sal

Country Status (28)

Country Link
US (2) US20130150324A1 (es)
EP (5) EP3666257A1 (es)
JP (1) JP6142419B2 (es)
KR (1) KR102017922B1 (es)
CN (2) CN104114152A (es)
AR (1) AR089123A1 (es)
AU (2) AU2012347459A1 (es)
BR (1) BR112014013820A8 (es)
CA (1) CA2858574C (es)
CL (1) CL2014001518A1 (es)
CO (1) CO6990739A2 (es)
DK (2) DK2787969T3 (es)
ES (2) ES2896336T3 (es)
HK (2) HK1201458A1 (es)
HU (2) HUE049489T2 (es)
IL (1) IL233008A (es)
IN (1) IN2014CN04809A (es)
MX (1) MX355216B (es)
MY (1) MY173378A (es)
PH (1) PH12014501296A1 (es)
PL (2) PL2787969T3 (es)
PT (2) PT2787968T (es)
RU (1) RU2014127074A (es)
SG (1) SG11201403013VA (es)
SI (2) SI2787969T1 (es)
TW (1) TWI652072B (es)
WO (2) WO2013086449A1 (es)
ZA (1) ZA201404228B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
PL3266446T3 (pl) 2016-07-07 2019-05-31 Salvat Lab Sa Kompozycja oftalmiczna zawierająca olej rycynowy i trójgliceryd o średniej długości łańcucha
WO2018035469A1 (en) 2016-08-19 2018-02-22 Akrivista, LLC Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
CN111295169A (zh) 2017-08-18 2020-06-16 阿克里维斯塔有限责任公司 诊断和治疗干眼综合症的方法和用于治疗人类眼睛的组合物
JP7490570B2 (ja) 2018-04-27 2024-05-27 アラーガン、インコーポレイテッド 抗微生物有効性の増強及び毒性の減少を有する亜塩素酸ナトリウム組成物

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201706A (en) 1978-09-22 1980-05-06 Burton, Parsons & Company, Inc. Treatment of corneal edema
EP0028110B1 (en) * 1979-10-26 1984-03-07 Smith and Nephew Associated Companies p.l.c. Autoclavable emulsions
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
IT1224795B (it) 1988-12-01 1990-10-24 Sigma Tau Ind Farmaceuti Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
JPH0723302B1 (es) 1989-08-03 1995-03-15
US5681555A (en) 1991-04-22 1997-10-28 Gleich; Gerald J. Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
DE4229494A1 (de) 1992-09-04 1994-03-10 Basotherm Gmbh Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
KR970705985A (ko) 1994-09-14 1997-11-03 우에하라 아끼라 각막 장해 복구용 점안제(Eye Drops for Repairing Corneal Disturbance)
US5980865A (en) 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
FI106923B (fi) 1997-01-03 2001-05-15 Cultor Ltd Finnsugar Bioproduc Trimetyyliglysiinin käyttö kehon limakalvojen hygieniaan ja hoitoon tarkoitetuissa valmisteissa
AR002194A1 (es) 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.
IT1302307B1 (it) 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
US6585987B1 (en) 1998-11-13 2003-07-01 Continental Projects Limited Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions
JP2000159659A (ja) 1998-11-30 2000-06-13 Kazuo Tsubota 眼科用人工涙液
US6228392B1 (en) 1999-04-29 2001-05-08 Gene Tools, Llc Osmotic delivery composition, solution, and method
RU2291685C2 (ru) 2000-07-14 2007-01-20 Аллерган Инк. Композиции, содержащие терапевтически активные компоненты, обладающие повышенной растворимостью
CA2355814C (en) 2000-09-14 2010-06-29 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition for ophthalmic use
AU2002227206B2 (en) 2000-11-08 2006-09-21 Fxs Ventures, Llc Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US7045121B2 (en) 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
WO2004028536A1 (en) 2002-09-30 2004-04-08 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
AU2003301263A1 (en) * 2002-10-18 2004-05-04 Joel S. Echols Three layer tear formulation
US20040137079A1 (en) 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US6635654B1 (en) * 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
WO2004084877A1 (ja) 2003-03-26 2004-10-07 Menicon Co., Ltd. 眼科用組成物
CA2839930C (en) * 2003-06-13 2016-07-05 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US20050009836A1 (en) 2003-06-26 2005-01-13 Laskar Paul A. Ophthalmic composition containing quinolones and method of use
CN1878571B (zh) * 2003-11-10 2010-09-08 东丽株式会社 含有多糖类的组合物及泪液层稳定化滴眼剂
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) * 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US9561178B2 (en) * 2006-07-25 2017-02-07 Allergan, Inc. Cyclosporin compositions
WO2008035246A2 (en) * 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
CN101896160A (zh) * 2006-10-17 2010-11-24 阿勒根公司 环胞菌素组合物
CN101668511A (zh) * 2007-02-28 2010-03-10 阿西克斯医疗公司 正常化睑板腺分泌的方法和化合物
JP4929245B2 (ja) 2008-07-31 2012-05-09 株式会社ベッセル工業 工具類のグリップ
MX2011013007A (es) * 2009-06-05 2012-02-28 Allergan Inc Lagrimas artificiales y usos terapeuticos.
WO2013049621A1 (en) * 2011-09-29 2013-04-04 The Board Of Regents Of The University Of Oklahoma Ophthalmic compositions comprising ppar-alpha agonists and methods of production and use thereof
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye

Also Published As

Publication number Publication date
PT2787968T (pt) 2020-06-16
EP2787969A1 (en) 2014-10-15
US20130150324A1 (en) 2013-06-13
MY173378A (en) 2020-01-21
EP2787969B1 (en) 2021-09-29
EP3666257A1 (en) 2020-06-17
AU2017265181A1 (en) 2017-12-14
MX355216B (es) 2018-04-10
TW201325633A (zh) 2013-07-01
JP2015504860A (ja) 2015-02-16
HK1203057A1 (en) 2015-10-16
KR20140107383A (ko) 2014-09-04
PL2787968T3 (pl) 2020-08-24
SI2787969T1 (sl) 2021-12-31
CA2858574A1 (en) 2013-06-13
EP3981387A1 (en) 2022-04-13
CL2014001518A1 (es) 2014-10-24
RU2018119362A (ru) 2018-11-08
ZA201404228B (en) 2015-12-23
EP2787968A1 (en) 2014-10-15
ES2797650T3 (es) 2020-12-03
BR112014013820A2 (pt) 2017-06-13
CA2858574C (en) 2017-05-30
WO2013086449A1 (en) 2013-06-13
RU2018119362A3 (es) 2021-09-07
AR089123A1 (es) 2014-07-30
AU2017265181B2 (en) 2019-06-20
IL233008A0 (en) 2014-07-31
HUE049489T2 (hu) 2020-09-28
ES2896336T3 (es) 2022-02-24
SI2787968T1 (sl) 2020-08-31
EP4403220A3 (en) 2024-10-23
EP2787968B1 (en) 2020-03-04
CN108969482A (zh) 2018-12-11
PH12014501296A1 (en) 2014-10-08
BR112014013820A8 (pt) 2017-06-13
SG11201403013VA (en) 2014-07-30
JP6142419B2 (ja) 2017-06-07
HK1201458A1 (en) 2015-09-04
DK2787968T3 (da) 2020-06-02
PL2787969T3 (pl) 2021-12-20
US20130197083A1 (en) 2013-08-01
EP4403220A2 (en) 2024-07-24
IN2014CN04809A (es) 2015-09-18
DK2787969T3 (da) 2021-11-01
KR102017922B1 (ko) 2019-09-03
IL233008A (en) 2017-07-31
HUE057140T2 (hu) 2022-04-28
AU2012347459A1 (en) 2014-07-03
MX2014006804A (es) 2014-09-22
WO2013086438A1 (en) 2013-06-13
RU2014127074A (ru) 2016-02-10
TWI652072B (zh) 2019-03-01
US9314528B2 (en) 2016-04-19
CN104114152A (zh) 2014-10-22
PT2787969T (pt) 2021-11-09

Similar Documents

Publication Publication Date Title
CO6990739A2 (es) Administración eficiente de lípidos a la película lagrimal humana mediante el uso de un sistema de emulsión sensible a la sal
BR112013023618A2 (pt) sistema para controlar a propulsão de um veículo
CO7000779A2 (es) Sistema de administración transdermica
BR112014006865A2 (pt) sistema para direcionar luz
CL2014000183A1 (es) Formulación farmacéutica que contienen anticuerpos anti-pcsk9; metodo para preparar dicha formulación.
CR20130406A (es) Composiciones farmacéuticas que comprenden anticuerpos humanos frente a pcsk9
DK3192501T3 (da) Topisk farmaceutisk sammensætning baseret på semifluorerede alkaner
FR2984278B1 (fr) Systeme d'assistance au pilote d'un aeronef par des moyens haptiques
BR112012023973A2 (pt) sistema configurado para monitorar reanimação cardiopulmonar
BR112013028864A2 (pt) fechos livres de pvc
BR112013033110A2 (pt) sistema de composição para demarcação de pavimento
CO7010828A2 (es) Preparación farmacéutica que comprende ߖciclodextrina sustituida
FR2973708B1 (fr) Dispositif d'assistance respiratoire
FR2971626B1 (fr) Film bi-couches d'un module photovoltaique
FR2995092B1 (fr) Systeme d'assistance a la tenue du vol stationnaire d'un helicoptere
BR112014006647A2 (pt) sistema adaptado para treinar um jogador desportivo
FI20115695A (fi) Lentoestevalaisin
DK2530780T3 (da) Fremgangsmåde til administration af et hybridsystems funktion
BR112014008339A2 (pt) sistema de cromatografia e utilização de um sistema de cromatografia e da proporção
FR2974243B1 (fr) Film bi-couches d'un module photovoltaique
CO6880061A2 (es) Método para tratar el cáncer mediante el uso combinado de fármacos
FR3009842B1 (fr) Procede d'assemblage de deux pales d'un distributeur de turbomachine
ES1075720Y (es) Aposito para cubrir el punto de puncion de un cateter
FI10064U1 (fi) Järjestelmä käyttäjien esittelemiseksi toisilleen
FR2987124B1 (fr) Systeme d'ingestion de cendres volcaniques